For decades, researchers and medical professionals have pursued a more concrete understanding of migraine headaches. We're still not sure of the origin of migraines, but we may have found a device that minimizes their impact. Dr. Richard Lipton, professor and vice chair of neurology at Albert Einstein College of Medicine, and director of the Montefiore Headache Center in New York City, shares details on this device with host Dr. Mark Nolan Hill.
A Novel Migraine-Minimizing Device
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
For decades, researchers and medical professionals have pursued a more concrete understanding of migraine headaches. We're still not sure of the origin of migraines, but we may have found a device that minimizes their impact. Dr. Richard Lipton, professor and vice chair of neurology at Albert Einstein College of Medicine, and director of the Montefiore Headache Center in New York City, shares details on this device with host Dr. Mark Nolan Hill.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Updates From the 7th World Symposium Task Force
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?